<DOC>
	<DOCNO>NCT00569543</DOCNO>
	<brief_summary>RATIONALE : Studying sample urine laboratory woman breast cancer may help doctor learn whether tamoxifen aromatase inhibitor alter metabolism estrogen . PURPOSE : This clinical trial study effect tamoxifen aromatase inhibitor estrogen metabolism woman undergo treatment newly diagnose breast cancer .</brief_summary>
	<brief_title>Effect Tamoxifen Aromatase Inhibitor Estrogen Metabolism Women Undergoing Treatment Newly Diagnosed Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Learn effect select chemotherapy agent profile estrogen metabolite , glutathione conjugate , depurinating DNA adduct urine woman breast cancer . - Determine whether tamoxifen citrate aromatase inhibitor alters metabolism estrogens . OUTLINE : Patients stratify accord plan therapy ( tamoxifen citrate v aromatase inhibitor ) . Patients receive tamoxifen citrate aromatase inhibitor plan . Urine sample ( nipple aspirate fluid , possible ) collect begin treatment 2-6 month treatment . Samples analyze 40 estrogen metabolite , conjugate , depurinating DNA adduct ultraperformance liquid chromatography tandem mass spectrometric detection . Patients ' information , include race , body mass index , age menarche , menopausal status , age menopause applicable , smoke history , alcohol consumption , pregnancy history include age pregnancy , lactation , history benign breast disease , hysterectomy , disease type , collect medical record review .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose ductal carcinoma situ invasive breast cancer Scheduled receive tamoxifen citrate aromatase inhibitor Estrogen receptor progesterone receptor positive PATIENT CHARACTERISTICS : Menopausal status specify ECOG performance status 0 , 1 , 2 Not pregnant nursing PRIOR CONCURRENT THERAPY : No prior antiestrogen drug tamoxifen citrate raloxifene No concurrent estrogen</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>breast cancer situ</keyword>
	<keyword>ductal breast carcinoma situ</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
</DOC>